As of 2026-05-31, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (0.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.49 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -104.5%.
The range of the Relative Valuation is (1.39) - 0.31 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 21.2x | 18.1x |
| Forward P/E multiples | 20.6x - 24.7x | 21.3x |
| Fair Price | (1.39) - 0.31 | (0.65) |
| Upside | -109.6% - -97.9% | -104.5% |
| Date | P/E |
| 2026-04-27 | -167.83 |
| 2026-04-24 | -167.83 |
| 2026-04-23 | -167.48 |
| 2026-04-22 | -167.48 |
| 2026-04-21 | -167.48 |
| 2026-04-20 | -167.48 |
| 2026-04-17 | -167.48 |
| 2026-04-16 | -167.37 |
| 2026-04-15 | -167.48 |
| 2026-04-14 | -167.48 |
| 2026-04-13 | -167.48 |
| 2026-04-10 | -167.48 |
| 2026-04-09 | -167.60 |
| 2026-04-08 | -167.48 |
| 2026-04-07 | -167.60 |
| 2026-04-06 | -167.37 |
| 2026-04-02 | -167.25 |
| 2026-04-01 | -167.25 |
| 2026-03-31 | -167.48 |
| 2026-03-30 | -167.13 |
| 2026-03-27 | -166.90 |
| 2026-03-26 | -167.13 |
| 2026-03-25 | -167.13 |
| 2026-03-24 | -166.90 |
| 2026-03-23 | -167.02 |
| 2026-03-20 | -167.13 |
| 2026-03-19 | -166.56 |
| 2026-03-18 | -166.44 |
| 2026-03-17 | -166.44 |
| 2026-03-16 | -166.44 |
| 2026-03-13 | -166.44 |
| 2026-03-12 | -166.44 |
| 2026-03-11 | -166.44 |
| 2026-03-10 | -166.32 |
| 2026-03-09 | -166.44 |
| 2026-03-06 | -166.09 |
| 2026-03-05 | -165.98 |
| 2026-03-04 | -165.98 |
| 2026-03-03 | -166.09 |
| 2026-03-02 | -166.32 |